Isoray (NYSE:ISR) Now Covered by assumed coverage on shares of Isoray (NYSE:ISRGet Rating) in a note issued to investors on Tuesday. The firm set a “sell” rating on the stock.

Isoray stock opened at $0.33 on Tuesday. The firm has a market cap of $47.30 million, a PE ratio of -6.66 and a beta of 0.98. The stock has a fifty day simple moving average of $0.35. Isoray has a 1-year low of $0.31 and a 1-year high of $0.98.

About Isoray (Get Rating)

Isoray, Inc, through its subsidiary, IsoRay Medical, Inc, develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers.

Recommended Stories

Receive News & Ratings for Isoray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Isoray and related companies with's FREE daily email newsletter.